THRD - Third Harmonic Bio, Inc.
IEX Last Trade
10.59
0 0%
Share volume: 609
Last Updated: Thu 26 Dec 2024 08:27:24 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$10.59
0.00
0.00%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
-4.44%
1 Month
-20.19%
3 Months
-22.55%
6 Months
-17.77%
1 Year
-8.02%
2 Year
145.13%
Key data
Stock price
$10.59
DAY RANGE
$10.34 - $10.71
52 WEEK RANGE
$8.78 - $16.69
52 WEEK CHANGE
-$9.71
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: Natalie C. Holles
Region: US
Website: thirdharmonicbio.com
Employees: 20
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: thirdharmonicbio.com
Employees: 20
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
We are a clinical-stage biopharmaceutical company focused on the development of the next wave of medicine for the treatment of allergic and inflammatory diseases. Our principal executive offices are located at 300 Technology Square, 8th Floor, Cambridge, Massachusetts.
Recent news